Australian Paediatric Surveillance Unit annual report, 2013

Related Experiment Video

Updated: Apr 18, 2026

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
05:15

Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport

Published on: June 21, 2024

1.6K

Marie Deverell1, Yvonne A Zurynski1, Elizabeth J Elliott2

  • 1Australian Paediatric Surveillance Unit, Kids Research Institute, Westmead, New South Wales and Discipline of Paediatrics and Child Health, Sydney Medical School, University of Sydney, New South Wales.

Communicable Diseases Intelligence Quarterly Report
|January 30, 2015
PubMed

Insights

The Australian Paediatric Surveillance Unit (APSU) monitored uncommon childhood diseases in 2013. This surveillance tracked conditions like acute flaccid paralysis and congenital infections, providing crucial public health data.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • The Australian Paediatric Surveillance Unit (APSU) conducts national active surveillance.
  • This surveillance focuses on uncommon diseases in childhood, including specific communicable diseases.

Purpose of the Study:

  • To provide an update on the surveillance data collected by the APSU from January to December 2013.
  • To report on the incidence and trends of various uncommon childhood diseases.

Main Methods:

  • National active surveillance facilitated by the APSU.
  • Data collection on specified pediatric conditions throughout 2013.
  • Targeted surveillance for severe influenza complications during the 2013 influenza season.

Main Results:

  • Surveillance data was gathered for acute flaccid paralysis (AFP), congenital cytomegalovirus (cCMV), congenital rubella, perinatal HIV exposure, pediatric HIV infection, neonatal herpes simplex virus (HSV), congenital varicella, neonatal varicella, severe varicella complications, and juvenile onset recurrent respiratory papillomatosis (JoRRP).
  • Specific data on severe influenza complications were collected during the July to September 2013 influenza season.

Conclusions:

  • The APSU successfully conducted surveillance for a range of uncommon pediatric diseases in 2013.
  • The collected data contributes to understanding the epidemiology of these conditions in Australian children.

More Related Videos

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

5.1K
A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

7.8K

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
821
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
882